Combination Therapy and Appropriate Dosing to Target KRAS in Colorectal Cancer

N Engl J Med. 2023 Dec 7;389(23):2197-2199. doi: 10.1056/NEJMe2311611.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Colorectal Neoplasms* / drug therapy
  • Colorectal Neoplasms* / genetics
  • Combined Modality Therapy
  • Humans
  • Proto-Oncogene Proteins p21(ras)* / genetics

Substances

  • Proto-Oncogene Proteins p21(ras)
  • KRAS protein, human